Autolus Therapeutics (AUTL) Selling, General & Administrative (2017 - 2026)
Autolus Therapeutics' Selling, General & Administrative was $41.16 million in Q2 2026, up 36.0% from $30.27 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Autolus Therapeutics' Selling, General & Administrative was $143.5 million through Jun 30, 2026, up 18.2% year-over-year; for FY2025, it came in at $131.87 million, up 29.6% from FY2024.
- Selling, General & Administrative has now increased for four consecutive years, with a five-year compound annual growth rate of 30.4% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $101.72 million in FY2024 (+117.6%), $46.75 million in FY2023 (+46.5%), $31.9 million in FY2022 (+0.1%) and $31.87 million in FY2021 (-8.9%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2018.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2024 (growth of 157.6%); the worst was Q4 2021 (a decline of 15.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Autolus Therapeutics | 631.98 Mn | -692.11 Mn | 25.22 Mn | 41.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.16 Mn |
| Dec 31, 2025 | 35.80 Mn |
| Sep 30, 2025 | 36.28 Mn |
| Jun 30, 2025 | 30.27 Mn |
| Mar 31, 2025 | 29.53 Mn |
| Dec 31, 2024 | 34.31 Mn |
| Sep 30, 2024 | 27.33 Mn |
| Jun 30, 2024 | 21.90 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Dec 31, 2023 | 15.73 Mn |
| Sep 30, 2023 | 10.61 Mn |
| Jun 30, 2023 | 11.12 Mn |
| Mar 31, 2023 | 9.28 Mn |
| Dec 31, 2022 | 7.41 Mn |
| Sep 30, 2022 | 8.23 Mn |
| Jun 30, 2022 | 8.27 Mn |
| Mar 31, 2022 | 7.99 Mn |
| Dec 31, 2021 | 7.59 Mn |
| Sep 30, 2021 | 8.30 Mn |
| Jun 30, 2021 | 7.24 Mn |
API Access
Autolus Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();